Holen Sie sich die Stockscreener-App
0.5384
3.06%
-0.017
Handel nachbörslich:
.53
-0.0084
-1.56%
Schlusskurs vom Vortag:
$0.5554
Offen:
$0.588
24-Stunden-Volumen:
827.67K
Relative Volume:
2.85
Marktkapitalisierung:
$11.81M
Einnahmen:
$4.03M
Nettoeinkommen (Verlust:
$24.32M
KGV:
-0.1252
EPS:
-4.3008
Netto-Cashflow:
$-45.76M
1W Leistung:
+10.87%
1M Leistung:
+28.16%
6M Leistung:
-25.24%
1J Leistung:
-51.05%
1-Tages-Spanne:
$0.4965
$0.59
1-Wochen-Bereich:
$0.4505
$0.5998
52-Wochen-Spanne:
$0.304
$1.25
Pavmed Inc Stock (PAVM) Company Profile
Firmenname
Pavmed Inc
Sektor
Branche
Telefon
(212) 949-4319
Adresse
360 MADISON AVENUE, NEW YORK, NY
Vergleichen Sie PAVM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
0.5384 | 12.18M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
133.27 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.00 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.54 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.36 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Eingeleitet | Maxim Group | Buy |
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
Volume spikes in PAVmed Inc. stock – what they meanQuarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com
Will PAVmed Inc. stock split again soon2025 Year in Review & Short-Term Trading Opportunity Alerts - newser.com
Using R and stats models for PAVmed Inc. forecastingRate Hike & Precise Swing Trade Entry Alerts - newser.com
What momentum shifts mean for PAVmed Inc.2025 Earnings Surprises & Low Risk Entry Point Guides - newser.com
Will PAVmed Inc. stock recover faster than peersEarnings Recap Summary & Fast Entry High Yield Tips - newser.com
PAVmed (PAVM) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Statistical indicators supporting PAVmed Inc.’s strengthJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com
Will PAVmed Inc. rebound enough to break evenDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com
What high frequency data says about PAVmed Inc.2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com
Analyzing PAVmed Inc. with multi timeframe chartsQuarterly Earnings Report & Entry and Exit Point Strategies - newser.com
PAVmed subsidiary Veris Health launches cancer care platform at OSU center - Investing.com Canada
Pavmed subsidiary, Veris Health and the Ohio State University Comprehensive Cancer Center launch commercial phase of strategic partnership agreement - MarketScreener
Commercial phase launch: Veris platform deployed at OSUCCC–James by PAVmed to expand care - Stock Titan
What Fibonacci levels say about PAVmed Inc. rebound2025 Price Action Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Why analysts upgrade PAVmed Inc. stockBreakout Watch & High Return Trade Guides - newser.com
Ascendiant Capital Maintains PAVmed (PAVM) Buy Recommendation - Nasdaq
PAVmed Inc Stock Analysis and ForecastREITs Market Trends & Small Budget Capital Growth - earlytimes.in
PAVM: Ascendiant Capital Raises Price Target with Continued 'Buy - GuruFocus
Key metrics from PAVmed Inc.’s quarterly data2025 Volatility Report & Intraday High Probability Alerts - newser.com
Comparing PAVmed Inc. in custom built stock radarsTrade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
What data driven models say about PAVmed Inc.’s futureChart Signals & Consistent Profit Alerts - newser.com
Real time pattern detection on PAVmed Inc. stockQuarterly Earnings Summary & Real-Time Volume Analysis - newser.com
Transcript : PAVmed Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Finanzdaten der Pavmed Inc-Aktie (PAVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):